Thomas J. Herzfeld Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-417	Closed	-$46K	–	356
2021 Q2	$46K	Hold	417	–	–	0.02%	149
2021 Q1	$46K	Hold	417	–	–	0.02%	153
2020 Q4	$44K	Hold	417	–	–	0.02%	149
2020 Q3	$49K	Hold	417	–	–	0.03%	98
2020 Q2	$97K	Hold	417	–	–	0.05%	113
2020 Q1	$37K	Hold	417	–	–	0.02%	131
2019 Q4	$17K	Hold	417	–	–	0.01%	165
2019 Q3	$10K	Hold	417	–	–	﹤0.01%	205
2019 Q2	$15K	Hold	417	–	–	0.01%	194
2019 Q1	$19K	Hold	417	–	–	0.01%	212
2018 Q4	$20K	Hold	417	–	–	0.01%	210
2018 Q3	$28K	Hold	417	–	–	0.01%	187
2018 Q2	$20K	Hold	417	–	–	0.01%	217
2018 Q1	$24K	Hold	417	–	–	0.01%	224
2017 Q4	$21K	Sell	417 -833	-67%	-$51.6K	0.01%	229
2017 Q3	$95K	Hold	1,250	–	–	0.04%	148
2017 Q2	$118K	Hold	1,250	–	–	0.05%	139
2017 Q1	$99K	Hold	1,250	–	–	0.04%	163
2016 Q4	$104K	Hold	1,250	–	–	0.05%	153
2016 Q3	$140K	Hold	1,250	–	–	0.07%	114
2016 Q2	$139K	Hold	1,250	–	–	0.07%	124
2016 Q1	$131K	Hold	1,250	–	–	0.07%	136
2015 Q4	$101K	Hold	1,250	–	–	0.04%	170
2015 Q3	$87K	Hold	1,250	–	–	0.04%	163
2015 Q2	$122K	Hold	1,250	–	–	0.05%	148
2015 Q1	$122K	Buy	+1,250	New	+$121K	0.06%	149

Other funds holding INO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Thomas J. Herzfeld Advisors's INO Position: Q3 2021 in Review

Thomas J. Herzfeld Advisors sold out of Inovio Pharmaceuticals (INO) in Q3 2021, closing a stake of 417 shares — an estimated $46K sold.

Thomas J. Herzfeld Advisors first reported a position in INO in Q1 2015 and held it in 26 quarters. The position peaked at $140K in Q3 2016. 213 funds tracked by Wall St. Rank hold INO as of Q3 2021.

Thomas J. Herzfeld Advisors reported no remaining Inovio Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Thomas J. Herzfeld Advisors sold 417 Inovio Pharmaceuticals shares in Q3 2021, an estimated $46K.
Thomas J. Herzfeld Advisors first reported a position in Inovio Pharmaceuticals in Q1 2015 and held it in 26 quarters.
Thomas J. Herzfeld Advisors's Inovio Pharmaceuticals position peaked at $140K in Q3 2016.
213 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2021.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.